NTI Appendix 4G and Corporate Governance Statement 29/08/25 download Created with Sketch. 530.48KB Share NTI Appendix 4E & Annual Report to shareholders 29/08/25 PRICE SENSITIVE download Created with Sketch. 2.03MB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 31/07/25 PRICE SENSITIVE download Created with Sketch. 380.56KB Share NTI Change of Registered Address & Principal Place of Business 10/07/25 download Created with Sketch. 83.83KB Share NTI Becoming a substantial holder 09/07/25 download Created with Sketch. 171.47KB Share NTI New Scientific Publication of Phase I/II Rett Syndrome Trial 07/07/25 download Created with Sketch. 265.77KB Share NTI NTI Appoints Dr. Bonni Goldstein as Chief Medical Advisor 16/06/25 download Created with Sketch. 126.5KB Share NTI NTI164 to be presented at IRSF Annual Scientific Meeting 06/06/25 download Created with Sketch. 99.98KB Share NTI Positive Human PK Study Results for NTI164 02/06/25 PRICE SENSITIVE download Created with Sketch. 123.18KB Share NTI NTI164 Preclinical Toxicology Studies Update 05/05/25 PRICE SENSITIVE download Created with Sketch. 112.86KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 28/04/25 PRICE SENSITIVE download Created with Sketch. 314.41KB Share NTI Updated Trading Policy 16/04/25 download Created with Sketch. 165.86KB Share NTI Secondary Trading Notice 02/04/25 download Created with Sketch. 86.58KB Share NTI Application for quotation of securities - NTI 02/04/25 download Created with Sketch. 15.8KB Share NTI Final Director's Interest Notice 02/04/25 download Created with Sketch. 151.91KB Share NTI Resignation of Executive Director 01/04/25 download Created with Sketch. 101.1KB Share NTI European Commission grants NTI164 ODD for Rett Syndrome 31/03/25 download Created with Sketch. 107.49KB Share NTI Retraction of Statement 26/03/25 download Created with Sketch. 69.59KB Share NTI New Scientific Publication of Phase I/II Autism Trial 24/03/25 download Created with Sketch. 118.05KB Share NTI Neurotech Presentation at NWR Virtual Healthcare Conference 20/03/25 download Created with Sketch. 4.94MB Share NTI Neurotech to present at NWR Virtual Healthcare Conference 18/03/25 download Created with Sketch. 74.41KB Share NTI Appendix 4D and Half Year Accounts 27/02/25 PRICE SENSITIVE download Created with Sketch. 1006.37KB Share NTI Positive Opinion on OMPD for NTI164 in Europe 27/02/25 PRICE SENSITIVE download Created with Sketch. 119.43KB Share NTI Change of Director's Interest Notice 24/02/25 download Created with Sketch. 159.27KB Share NTI Notification regarding unquoted securities - NTI 24/02/25 download Created with Sketch. 22.35KB Share NTI NTI Signs Development Agreement for Cannabinoid Therapies 13/02/25 PRICE SENSITIVE download Created with Sketch. 127.25KB Share NTI Initial Director's Interest Notice 04/02/25 download Created with Sketch. 139.54KB Share NTI Neurotech Receives $2.44 Million R&D Tax Incentive Refund 31/01/25 PRICE SENSITIVE download Created with Sketch. 134.52KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 29/01/25 PRICE SENSITIVE download Created with Sketch. 349.64KB Share NTI Notice of Expiry of Listed Options 17/12/24 download Created with Sketch. 150.08KB Share NTI Becoming a substantial holder 12/12/24 download Created with Sketch. 266.02KB Share NTI Change of Director's Interest Notice 06/12/24 download Created with Sketch. 177.41KB Share NTI Resignation of Joint Company Secretary 02/12/24 download Created with Sketch. 83.84KB Share NTI Secondary Trading Notice 02/12/24 download Created with Sketch. 84.39KB Share NTI Application for quotation of securities - NTI 02/12/24 download Created with Sketch. 15.79KB Share NTI Neurotech Receives US ODD in Rett Syndrome 26/11/24 PRICE SENSITIVE download Created with Sketch. 127.66KB Share NTI NTI Receives Ethics Approval to Commence Human PK Study 25/11/24 PRICE SENSITIVE download Created with Sketch. 129.34KB Share NTI Notification of cessation of securities - NTI 20/11/24 download Created with Sketch. 12.88KB Share NTI Results of Annual General Meeting 20/11/24 download Created with Sketch. 94.16KB Share NTI 2024 AGM Chairman Address and Investor Presentation 20/11/24 download Created with Sketch. 1.25MB Share NTI Positive Genomic Effects of NTI164 in PANDAS/PANS Patients 15/11/24 PRICE SENSITIVE download Created with Sketch. 211KB Share NTI New Scientific Publication Highlights Benefits of NTI164 12/11/24 download Created with Sketch. 159.89KB Share NTI Proposed issue of securities - NTI 11/11/24 download Created with Sketch. 19.83KB Share NTI Neurotech Appoints Dr Anthony Filippis as MD/CEO 11/11/24 PRICE SENSITIVE download Created with Sketch. 118.54KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 23/10/24 PRICE SENSITIVE download Created with Sketch. 410.52KB Share NTI Notice of Annual General Meeting/Proxy Form 16/10/24 download Created with Sketch. 483.01KB Share NTI Becoming a substantial holder 08/10/24 download Created with Sketch. 120.58KB Share NTI US FDA Response to Orphan Drug Request in PANDAS/PANS 04/10/24 PRICE SENSITIVE download Created with Sketch. 103.42KB Share NTI Upcoming Presentation of Rett Syndrome Clinical Data 24/09/24 download Created with Sketch. 169.66KB Share NTI Change of Director's Interest Notice 20/09/24 download Created with Sketch. 138.88KB Share NTI Notification regarding unquoted securities - NTI 20/09/24 download Created with Sketch. 14.48KB Share NTI Notification of cessation of securities - NTI 18/09/24 download Created with Sketch. 13.05KB Share NTI Secondary Trading Notice 18/09/24 download Created with Sketch. 99.62KB Share NTI Notification regarding unquoted securities - NTI 18/09/24 download Created with Sketch. 18.16KB Share NTI Application for quotation of securities - NTI 18/09/24 download Created with Sketch. 16.04KB Share NTI Becoming a substantial holder 17/09/24 download Created with Sketch. 164.63KB Share NTI Ceasing to be a substantial holder 17/09/24 download Created with Sketch. 147.22KB Share NTI Application for quotation of securities - NTI 17/09/24 download Created with Sketch. 15.59KB Share NTI Results of General Meeting 10/09/24 download Created with Sketch. 94.14KB Share NTI NTI164 Reverses Immune Dysregulation in PANDAS/PANS Children 09/09/24 PRICE SENSITIVE download Created with Sketch. 160.17KB Share NTI Neurotech ESG Report 30/08/24 download Created with Sketch. 1.17MB Share NTI US FDA orphan drug designation requested for Rett Syndrome 30/08/24 download Created with Sketch. 105.58KB Share NTI Secondary Trading Notice 27/08/24 download Created with Sketch. 70.3KB Share NTI Application for quotation of securities - NTI 27/08/24 download Created with Sketch. 15.58KB Share NTI Appendix 4G and Corporate Governance Statement 26/08/24 download Created with Sketch. 489.94KB Share NTI Appendix 4E & Annual Report to shareholders 26/08/24 PRICE SENSITIVE download Created with Sketch. 8.99MB Share NTI Neurotech to present at Investor Verse Biotech Workshop 13/08/24 download Created with Sketch. 1.46MB Share NTI Neurotech Global Partnering and Registration Strategy 12/08/24 PRICE SENSITIVE download Created with Sketch. 185.09KB Share NTI Notice of General Meeting/Proxy Form 09/08/24 download Created with Sketch. 505.39KB Share NTI Further Significant Improvement in Rett Syndrome Patients 31/07/24 PRICE SENSITIVE download Created with Sketch. 297.53KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 25/07/24 PRICE SENSITIVE download Created with Sketch. 671.56KB Share NTI Phase II/III autism trial shows further benefits 18/07/24 PRICE SENSITIVE download Created with Sketch. 194.28KB Share NTI Investor Presentation 10/07/24 download Created with Sketch. 1.55MB Share NTI Significant improvement in Autism patients at 12 weeks 10/07/24 PRICE SENSITIVE download Created with Sketch. 347.14KB Share NTI US FDA orphan drug designation requested for PANDAS/PANS 09/07/24 download Created with Sketch. 106.33KB Share NTI Appointment of Chief Medical Officer 05/07/24 download Created with Sketch. 140.64KB Share NTI Release of Shares from Voluntary Escrow 01/07/24 download Created with Sketch. 82.77KB Share NTI Expert PANDAS/PANS panel established post TGA meeting 28/06/24 download Created with Sketch. 139.08KB Share NTI Investor Presentation 17/06/24 download Created with Sketch. 2.29MB Share NTI Phase I/II Autism Patients Meet 2 Years of NTI164 Treatment 17/06/24 PRICE SENSITIVE download Created with Sketch. 190.62KB Share NTI Further clinical benefit at 52 weeks in PANDAS/PANS patients 06/06/24 PRICE SENSITIVE download Created with Sketch. 190.18KB Share NTI NTI Formalises Strategic Partnership with Fenix Innovation 03/06/24 download Created with Sketch. 146.77KB Share NTI Notice of Change of Auditor 08/05/24 download Created with Sketch. 83.71KB Share NTI Change of Director's Interest Notice 08/05/24 download Created with Sketch. 1.08MB Share NTI Investor Webinar on Rett Syndrome Clinical Trial Results 06/05/24 download Created with Sketch. 85.16KB Share NTI Investor Presentation 06/05/24 download Created with Sketch. 1.77MB Share NTI Rett Syndrome Phase I/II trial shows significant benefits 06/05/24 PRICE SENSITIVE download Created with Sketch. 593.85KB Share NTI Trading Halt 03/05/24 PRICE SENSITIVE download Created with Sketch. 140.26KB Share NTI Neurotech Receives $10 Million in Placement Funds 24/04/24 download Created with Sketch. 83.91KB Share NTI Notification regarding unquoted securities - NTI 24/04/24 download Created with Sketch. 17.64KB Share NTI Secondary Trading Notice 24/04/24 download Created with Sketch. 91.73KB Share NTI Application for quotation of securities - NTI 24/04/24 download Created with Sketch. 15.81KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 23/04/24 PRICE SENSITIVE download Created with Sketch. 445.81KB Share NTI Initial Director's Interest Notice 19/04/24 download Created with Sketch. 125.34KB Share NTI Final Director's Interest Notice 19/04/24 download Created with Sketch. 130.37KB Share NTI Proposed issue of securities - NTI 19/04/24 download Created with Sketch. 16.84KB Share NTI Board Changes 19/04/24 download Created with Sketch. 102.61KB Share NTI Investor Presentation 17/04/24 download Created with Sketch. 2.32MB Share NTI Proposed issue of securities - NTI 17/04/24 download Created with Sketch. 18.84KB Share NTI Neurotech Completes $10 Million Capital Raise 17/04/24 PRICE SENSITIVE download Created with Sketch. 193.4KB Share
(20min delay)
